Analyzing Sagimet Biosciences Inc (SGMT)’s quick and current ratios

Sagimet Biosciences Inc (NASDAQ: SGMT) closed the day trading at $5.24 up 0.19% from the previous closing price of $5.23. In other words, the price has increased by $+0.01 from its previous closing price. On the day, 585512 shares were traded. SGMT stock price reached its highest trading level at $5.30 during the session, while it also had its lowest trading level at $4.88.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.



For a better understanding of SGMT, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 17.04 and its Current Ratio is at 17.04. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on March 25, 2024, initiated with a Outperform rating and assigned the stock a target price of $26.

On August 08, 2023, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $67.Piper Sandler initiated its Overweight rating on August 08, 2023, with a $67 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 26 ’24 when Happel David bought 12,100 shares for $5.27 per share. The transaction valued at 63,731 led to the insider holds 639,200 shares of the business.

Happel David bought 1,600 shares of SGMT for $6,560 on Dec 07 ’23. The President & CEO now owns 627,100 shares after completing the transaction at $4.10 per share. On Nov 16 ’23, another insider, Happel David, who serves as the President & CEO of the company, bought 590 shares for $2.35 each. As a result, the insider paid 1,386 and bolstered with 590 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SGMT now has a Market Capitalization of 166.91M and an Enterprise Value of 72.08M. For the stock, the TTM Price-to-Sale (P/S) ratio is 60.00 while its Price-to-Book (P/B) ratio in mrq is 1.32. Its current Enterprise Value per Revenue stands at 36.04 whereas that against EBITDA is -2.34.

Stock Price History:

Over the past 52 weeks, SGMT has reached a high of $20.71, while it has fallen to a 52-week low of $2.13. The 50-Day Moving Average of the stock is 6.95, while the 200-Day Moving Average is calculated to be 8.11.

Shares Statistics:

Over the past 3-months, SGMT traded about 1.75M shares per day on average, while over the past 10 days, SGMT traded about 1.12M shares per day. A total of 21.38M shares are outstanding, with a floating share count of 12.11M. Insiders hold about 47.10% of the company’s shares, while institutions hold 53.11% stake in the company. Shares short for SGMT as of Mar 15, 2024 were 1.79M with a Short Ratio of 1.02, compared to 1.56M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 5.61% and a Short% of Float of 7.22%.

Earnings Estimates

Current recommendations for the stock of the company come from 5 analysts. The consensus estimate for the next quarter is -$0.42, with high estimates of -$0.29 and low estimates of -$0.6.

Analysts are recommending an EPS of between -$1.53 and -$2.62 for the fiscal current year, implying an average EPS of -$2.06. EPS for the following year is -$3.7, with 5 analysts recommending between -$2.62 and -$4.53.

Most Popular